Production of a Cost-Effective, TMV-Based Rabies Vaccine through Recombinant DNA Technology

Infectious diseases remain a significant cause of human deaths, as approximately 15 million deaths were attributed to infectious diseases in 2010 (Dye, 2014). One such disease is rabies, which causes around 59,000 human deaths worldwide annually according to some estimates (Kessels et al., 2017). Ho...

Full description

Bibliographic Details
Main Author: Halle, Briana
Format: Others
Published: Scholarship @ Claremont 2018
Subjects:
Online Access:http://scholarship.claremont.edu/cmc_theses/1816
http://scholarship.claremont.edu/cgi/viewcontent.cgi?article=2797&context=cmc_theses